Genomics is the study of genomes, which is the structure, function, evolution and mapping of an organism’s DNA. Overall, the market has influenced this area of human life in a great way over the years. Hence, medicine and biomedical sciences are in the process of a rapid transformation due to the genomics revolution. The increasing global cancer incidence has led to higher levels of government support in the form of grants for genomics projects. The idea of personalized medicine has been made possible by studying the Human Genome and has revolutionized the way clinical oncology and rare genetic disorders are managed/ treated.
Genomics Market size was valued at USD 37.1 billion in 2023 and is poised to grow from USD 41.66 billion in 2024 to USD 105.39 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).
Academics are increasingly exploring the link between genetics and cognitive disorders, to better understand the brain’s role in these conditions. Because of the increasing amount of research conducted on cancer and cancer therapy, the growing need for simple and rapid clinical diagnosis, and increased investment in R&D by government organizations and biopharmaceutical companies, the genomics market is experiencing rapid revenue growth.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/genomics-market
The 2025 global Genomics Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Genomics Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Genomics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Genomics Market is segmented by Offering, Product Type, Technology, Service Type, Application, Study Type, End User and region.
Based on Offering, the market is segmented into Products and Services.
Based on Product Type, the market is segmented into Reagents, Kits, And Consumables, Instruments and Bioinformatics Tools.
Based on Technology, the market is segmented into Sequencing, PCR, Gene Editing, Flow Cytometry, Microarrays, In Situ Hybridization and Other Technologies.
Based on Service Type, the market is segmented into Genomic Profiling and Sequencing Services, Sample Preparation and Library Preparation Services and Bioinformatics Services.
Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics and Other Applications.
Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics and Other Study Types.
Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Clinics, Academic and Research Institutes, Pharmaceutical And Biotechnology Companies and Other End Users.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Genomics Market – Regional Analysis:
North America dominated the market in terms of genomics market share in 2023 with a share of 42%. 65%, due mostly to the increased backing from research organizations and pharmaceutical companies. They keep changing the genetics, expression and health and therefore their influence makes genomics important in disease and drugs development. Some examples include the combination project initiated in January 2022 between Illumina, Inc. and Nashville Biosciences, LLC which is affiliated to the Vanderbilt University Medical Center.
Asia-Pacific is expected to grow at the highest CAGR during the forecast period owing to the increasing use of genomics for diagnostics as well as the development of new therapeutic drugs to tackle high disease rates in this region. The large-scale genome sequencing of thousands of Asian samples through projects like Genome Asia 100K, plan to sequence and analyse 100,000 genomes. It is believed that this project could bring progress for medical science especially in terms of developing new drugs for the population and creating comprehensive knowledge about diseases.
Top Market Players in Genomics Market are:
Illumina, Inc. (US)
Thermo Fisher Scientific (US)
Qiagen N.V. (Netherlands)
BGI Group (China)
F. Hoffmann-La Roche AG (Switzerland)
Danaher Corporation (US)
Pacific Biosciences of California, Inc. (US)
Oxford Nanopore Technologies, Ltd. (United Kingdom)
Eurofins Scientific SE (Luxembourg)
Bio-Rad Laboratories, Inc. (US)
Myriad Genetics, Inc. (US)
Fluidigm Corporation (US)
PerkinElmer, Inc. (US)
Twist Bioscience Corporation (US)
Natera, Inc. (US)
Veracyte, Inc. (US)
Personalis, Inc. (US)
10x Genomics, Inc. (US)
Quest Diagnostics (US)
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/genomics-market
Genomics Market Recent Developments:
In May 2024, SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company renowned for its leadership in data-driven medicine, announced a collaboration with Microsoft and NVIDIA. This partnership aims to utilize their combined expertise in technology and genomics to develop a streamlined and scalable whole genome sequencing (WGS) analytical solution for healthcare institutions, with plans to make the solution available to customers by the end of the year.
In March 2023, Illumina, Inc. (US) introduced Connected Insights, a cloud-based software designed for tertiary analysis of clinical next-generation sequencing data. This innovative tool aids in genomic profiling for advanced tumors and whole-genome sequencing for rare diseases, among other advanced applications.
In February 2023, Thermo Fisher Scientific, Inc. (US) unveiled the TrueMark STI Select Panel, a PCR test intended for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium, specifically for research purposes.
Take Action Now: Secure Your Genomics Market Today – https://www.skyquestt.com/buy-now/genomics-market
Forward-Looking Insights
The Genomics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
